Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hay

Showing results (411-420 of 423) with videos related to

Pageof 43
Sort By:
British Journal of Haematology|September 13, 2024
A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphomaJohn Kuruvilla, Christopher Rushton, Diego Villa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12Michael Crump, John Kuruvilla, Stephen Couban, et al.
NEJM Evidence|June 19, 2025
An Individualized Prediction Model for Early-Stage Classic Hodgkin's LymphomaAngie Mae Rodday, Andrew M Evens, Matthew J Maurer, et al.
Annals of Hematology|November 21, 2024
Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registryS Mathur, G Christou, R Delage, et al.
Transplantation and Cellular Therapy|November 10, 2025
Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular TherapyC Arianne Buchan, Gerard Agbayani, Katrina Hueniken, et al.
Proceedings. Biological Sciences|July 11, 2014
The tropicalization of temperate marine ecosystems: climate-mediated changes in herbivory and community phase shiftsAdriana Vergés, Peter D Steinberg, Mark E Hay, et al.
Blood Advances|January 27, 2026
Immunogenicity and Safety of a Third and Subsequent COVID-19 Vaccine Doses in Patients with Plasma Cell DyscrasiasSita Bhella, Gerard Agbayani, Katrina Hueniken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2026
Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trialKelvin Kw Chan, Ryan Wk Chu, Matthew C Cheung, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Relapse timing is associated with distinct evolutionary dynamics in DLBCLLaura K Hilton, Henry S Ngu, Brett Collinge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2023
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell LymphomaLaura K Hilton, Henry S Ngu, Brett Collinge, et al.
Pageof 43

Showing results (411-420 of 423) with videos related to

Sort By:
Pageof 43
British Journal of Haematology|September 13, 2024
A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphomaJohn Kuruvilla, Christopher Rushton, Diego Villa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12Michael Crump, John Kuruvilla, Stephen Couban, et al.
NEJM Evidence|June 19, 2025
An Individualized Prediction Model for Early-Stage Classic Hodgkin's LymphomaAngie Mae Rodday, Andrew M Evens, Matthew J Maurer, et al.
Annals of Hematology|November 21, 2024
Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registryS Mathur, G Christou, R Delage, et al.
Transplantation and Cellular Therapy|November 10, 2025
Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular TherapyC Arianne Buchan, Gerard Agbayani, Katrina Hueniken, et al.
Proceedings. Biological Sciences|July 11, 2014
The tropicalization of temperate marine ecosystems: climate-mediated changes in herbivory and community phase shiftsAdriana Vergés, Peter D Steinberg, Mark E Hay, et al.
Blood Advances|January 27, 2026
Immunogenicity and Safety of a Third and Subsequent COVID-19 Vaccine Doses in Patients with Plasma Cell DyscrasiasSita Bhella, Gerard Agbayani, Katrina Hueniken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2026
Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trialKelvin Kw Chan, Ryan Wk Chu, Matthew C Cheung, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Relapse timing is associated with distinct evolutionary dynamics in DLBCLLaura K Hilton, Henry S Ngu, Brett Collinge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2023
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell LymphomaLaura K Hilton, Henry S Ngu, Brett Collinge, et al.
Pageof 43